TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of sphingosine kinase

eLife

Volumn 4, Issue DECEMBER2015, 2015, Pages

  Etemadi, Nima ^a,b,c   Chopin, Michael ^a,b   Anderton, Holly ^a,b   Tanzer, Maria C ^a,b   Rickard, James A ^a,b   Abeysekera, Waruni ^a   Hall, Cathrine ^a   Spall, Sukhdeep K ^a   Wang, Bing ^d   Xiong, Yuquan ^e   Hla, Timothy ^e   Pitson, Stuart M ^f   Bonder, Claudine S ^f   Wong, Wendy Wei Lynn ^g   Ernst, Matthias ^c   Smyth, Gordon K ^a,b   Vaux, David L ^a,b   Nutt, Stephen L ^a,b   Nachbur, Ueli ^a,b   Silke, John ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f CENTRE FOR CANCER BIOLOGY   (Australia)

^g UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SPHINGOSINE KINASE 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL VIABILITY; CONTROLLED STUDY; DERMATITIS; EPIDERMIS HYPERPLASIA; FIBROBLAST; FLOW CYTOMETRY; HOMEOSTASIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSORIASIS; SIGNAL TRANSDUCTION; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; INFLAMMATION; METABOLISM; PATHOLOGY; SKIN;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; NF-KAPPA B; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PSORIASIS; SIGNAL TRANSDUCTION; SKIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84961262986     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.10592     Document Type: Article

References (80)

1. Adada MM, Orr-Gandy KA, Snider AJ, Canals D, Hannun YA, Obeid LM, Clarke CJ. 2013. Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor kB activation. Journal of Biological Chemistry 288:27667-27679. doi: 10.1074/jbc.M113.489443
2. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, Spiegel S, Proia RL. 2004. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. Journal of Biological Chemistry 279:52487-52492. doi: 10.1074/jbc.M406512200
3. Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T, Milstien S, Spiegel S. 2010. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465:1084-1088. doi: 10.1038/nature09128
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57:289-300.
5. Blackwell K, Zhang L, Workman LM, Ting AT, Iwai K, Habelhah H. 2013. Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed i b kinase activation. Molecular and Cellular Biology 33:1901-1915. doi: 10.1128/MCB.01416-12
6. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. doi: 10.1093/bioinformatics/19.2.185
7. Bonnet MC, Preukschat D, Welz P-S, van Loo G, Ermolaeva MA, Bloch W, Haase I, Pasparakis M. 2011. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35:572-582. doi: 10.1016/j.immuni.2011.08.014
8. Cheng H, Xu M, Liu X, Zou X, Zhan N, Xia Y. 2015. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation. Experimental Dermatology:n/a. doi: 10.1111/exd.12820
9. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM, Green DR. 2012. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148:988-1000. doi: 10.1016/j.cell.2012.01.038
10. Chopin M, Seillet C, Chevrier S, Wu L, Wang H, Morse HC, Belz GT, Nutt SL. 2013. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. Journal of Experimental Medicine 210: 2967-2980. doi: 10.1084/jem.20130930
11. Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, Eftychi C, Lin J, Corona T, Hermance N, Zelic M, Kirsch P, Basic M, Bleich A, Kelliher M, Pasparakis M. 2014. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513:90-94. doi: 10.1038/nature13608
12. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F, Gong Y-N, Janke LJ, Kelliher MA, Kanneganti T-D, Green DR. 2014. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157:1189-1202. doi: 10.1016/j.cell.2014.04.018
13. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, Helgason E, Fairbrother WJ, Deshayes K, Kirkpatrick DS, Vucic D. 2010. C-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. The EMBO Journal 29:4198-4209. doi: 10.1038/emboj.2010.300
14. Etemadi N, Holien JK, Chau D, Dewson G, Murphy JM, Alexander WS, Parker MW, Silke J, Nachbur U. 2013. Lymphotoxin a induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor. FEBS Journal 280:5283-5297. doi: 10.1111/febs.12419
15. Gardam S, Sierro F, Basten A, Mackay F, Brink R. 2008. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28:391-401. doi: 10.1016/j.immuni.2008.01.009
16. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H, Wong WW-L, Nachbur U, Gangoda L, Warnken U, Purcell AW, Silke J, Walczak H. 2011. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471:591-596. doi: 10.1038/nature09816
17. Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, Pham VC, Stephan J-P, Lill J, Ashkenazi A. 2012. TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Molecular Cell 48:888-899. doi: 10.1016/j.molcel.2012.09.031
18. Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. 2004. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21:629-642. doi: 10.1016/j.immuni.2004.09.011
19. Gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT. 2007. Mouse models of psoriasis. Journal of Investigative Dermatology 127:1292-1308. doi: 10.1038/sj.jid.5700807
20. Ha H-L, Wang H, Pisitkun P, Kim J-C, Tassi I, Tang W, Morasso MI, Udey MC, Siebenlist U. 2014. IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proceedings of the National Academy of Sciences of the United States of America 111:E3422-E3431. doi: 10.1073/pnas.1400513111
21. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T, Koschny R, Komander D, Silke J, Walczak H. 2009. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Molecular Cell 36:831-844. doi: 10.1016/j.molcel.2009.10.013
22. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S. 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325: 1254-1257. doi: 10.1126/science.1176709
23. Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P, Pierotti C, Garnier J-M, Dobson RCJ, Webb AI, Tripaydonis A, Babon JJ, Mulcair MD, Scanlon MJ, Alexander WS, Wilks AF, Czabotar PE, Lessene G, Murphy JM, Silke J. 2014. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proceedings of the National Academy of Sciences of the United States of America 111:15072-15077. doi: 10.1073/pnas.1408987111
24. Hjerpe R, Aillet F, Lopitz-Otsoa F, Lang V, England P, Rodriguez MS. 2009. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Reports 10:1250-1258. doi: 10.1038/embor.2009.192
25. Hla T, Dannenberg AJ. 2012. Sphingolipid signaling in metabolic disorders. Cell Metabolism 16:420-434. doi: 10.1016/j.cmet.2012.06.017
26. Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA. 2003. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient b lymphocytes reveal novel roles for TRAF2 in CD40 signaling. Journal of Biological Chemistry 278:45382-45390. doi: 10.1074/jbc.M306708200
27. Jabara HH, Laouini D, Tsitsikov E, Mizoguchi E, Bhan AK, Castigli E, Dedeoglu F, Pivniouk V, Brodeur SR, Geha RS. 2002. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17:265-276. doi: 10.1016/S1074-7613(02)00394-1
28. Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, Spiegel S. 1998. Molecular cloning and functional characterization of murine sphingosine kinase. Journal of Biological Chemistry 273:23722-23728. doi: 10.1074/jbc.273.37.23722
29. Kovalenko A, Kim J-C, Kang T-B, Rajput A, Bogdanov K, Dittrich-Breiholz O, Kracht M, Brenner O, Wallach D. 2009. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. Journal of Experimental Medicine 206:2161-2177. doi: 10.1084/jem.20090616
30. Kumari S, Redouane Y, Lopez-Mosqueda J, Shiraishi R, Romanowska M, Lutzmayer S, Kuiper J, Martinez C, Dikic I, Pasparakis M, Ikeda F. 2014. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife 3. doi: 10.7554/eLife.03422
31. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. 1997. TRAF2 is essential for JNK but not NF- kB activation and regulates lymphocyte proliferation and survival. Immunity 7:703-713. doi: 10.1016/S1074-7613(00)80390-8
32. Lin W-J, Su Y-W, Lu Y-C, Hao Z, Chio IIC, Chen N-J, Brustle A, Li WY, Mak TW. 2011. Crucial role for TNF receptor-associated factor 2 (tRAF2) in regulating NF B2 signaling that contributes to autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 108:18354-18359. doi: 10.1073/pnas.1109427108
33. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S. 2000. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. Journal of Biological Chemistry 275:19513-19520. doi: 10.1074/jbc.M002759200
34. Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J, Korneluk RG. 2008. Both cIAP1 and cIAP2 regulate TNF -mediated NF- b activation. Proceedings of the National Academy of Sciences of the United States of America 105:11778-11783. doi: 10.1073/pnas.0711122105
35. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang J-G, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, Young SN, Varghese LN, Tannahill GM, Hatchell EC, Majewski IJ, Okamoto T, Dobson RCJ, Hilton DJ, Babon JJ, Nicola NA, Strasser A, Silke J, Alexander WS. 2013. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39:443-453. doi: 10.1016/j.immuni.2013.06.018
36. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng B-J, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok P-Y, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR, Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Paschall J, Malloy MJ, Pullinger CR, Kane JP, Gardner J, Perlmutter A, Miner A, Feng B-J, Hiremagalore R, Ike RW, Lim HW, Christophers E, Henseler T, Schreiber S, Franke A, Ruether A, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok P-Y, Menter A, Lathrop GM, Wise C, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR. Collaborative Association Study of Psoriasis. 2009. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nature Genetics 41:199-204. doi: 10.1038/ng.311
37. Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D, Chambon P, Rajewsky K, Krieg T, Haase I, Pasparakis M. 2006. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Human Molecular Genetics 15:531-542. doi: 10.1093/hmg/ddi470
38. Nestle FO, Di Meglio P, Qin J-Z, Nickoloff BJ. 2009. Skin immune sentinels in health and disease. Nature Reviews Immunology 9:679-691. doi: 10.1038/nri2622
39. Panayotova-Dimitrova D, Feoktistova M, Ploesser M, Kellert B, Hupe M, Horn S, Makarov R, Jensen F, Porubsky S, Schmieder A, Zenclussen AC, Marx A, Kerstan A, Geserick P, He Y-W, Leverkus M. 2013. CFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Reports 5:397-408. doi: 10.1016/j.celrep.2013.09.035
40. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, Krampert M, Goebeler M, Gillitzer R, Israel A, Krieg T, Rajewsky K, Haase I. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417:861-866. doi: 10.1038/nature00820
41. Pasparakis M, Vandenabeele P. 2015. Necroptosis and its role in inflammation. Nature 517:311-320. doi: 10.1038/nature14191
42. Petersen SL, Chen TT, Lawrence DA, Marsters SA, Gonzalvez F, Ashkenazi A. 2015. TRAF2 is a biologically important necroptosis suppressor. Cell Death and Differentiation 22:1846-1857. doi: 10.1038/cdd.2015.35
43. Piao J-H, Hasegawa M, Heissig B, Hattori K, Takeda K, Iwakura Y, Okumura K, Inohara N, Nakano H. 2011. Tumor necrosis factor receptor-associated factor (tRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease. Journal of Biological Chemistry 286:17879-17888. doi: 10.1074/jbc.M111.221853
44. Pitson SM. 2011. Regulation of sphingosine kinase and sphingolipid signaling. Trends in Biochemical Sciences 36:97-107. doi: 10.1016/j.tibs.2010.08.001
45. Poon IKH, Chiu Y-H, Armstrong AJ, Kinchen JM, Juncadella IJ, Bayliss DA, Ravichandran KS. 2014. Unexpected link between an antibiotic, pannexin channels and apoptosis. Nature 507:329-334. doi: 10.1038/nature13147
46. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang Q-W, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nature Immunology 8:247-256. doi: 10.1038/ni1439
47. Rickard JA, Anderton H, Etemadi N, Nachbur U, Darding M, Peltzer N, Lalaoui N, Lawlor KE, Vanyai H, Hall C, Bankovacki A, Gangoda L, Wong WW-L, Corbin J, Huang C, Mocarski ES, Murphy JM, Alexander WS, Voss AK, Vaux DL, Kaiser WJ, Walczak H, Silke J. 2014a. TNFR1-dependent cell death drives inflammation in sharpin-deficient mice. eLife 3. doi: 10.7554/eLife.03464
48. Rickard JA, O’Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H, Hall C, Spall SK, Phesse TJ, Abud HE, Cengia LH, Corbin J, Mifsud S, Di Rago L, Metcalf D, Ernst M, Dewson G, Roberts AW, Alexander WS, Murphy JM, Ekert PG, Masters SL, Vaux DL, Croker BA, Gerlic M, Silke J. 2014b. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157: 1175-1188. doi: 10.1016/j.cell.2014.04.019
49. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43:e47. doi: 10.1093/nar/gkv007
50. Rothe M, Wong SC, Henzel WJ, Goeddel DV. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692. doi: 10.1016/0092-8674(94)90532-0
51. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S. 2003. TWEAK induces NF- B2 p100 processing and long lasting NF- b activation. Journal of Biological Chemistry 278:36005-36012. doi: 10.1074/jbc.M304266200
52. Shi C-S, Kehrl JH. 2003. Tumor necrosis factor (tNF)-induced germinal center kinase-related (gCKR) and stress-activated protein kinase (sAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (tRAF2). Journal of Biological Chemistry 278:15429-15434. doi: 10.1074/jbc.M211796200
53. Shinkura R, Matsuda F, Sakiyama T, Tsubata T, Hial H, Paumen M, Miyawaki S, Honjo T. 1996. Defects of somatic hypermutation and class switching in alymphoplasia (aly) mutant mice. International Immunology 8:1067-1075. doi: 10.1093/intimm/8.7.1067
54. Shu H-B, Takeuchi M, Goeddel DV. 1996. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proceedings of the National Academy of Sciences of the United States of America 93:13973-13978. doi: 10.1073/pnas.93.24.13973
55. Silke J, Brink R. 2010. Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death and Differentiation 17:35-45. doi: 10.1038/cdd.2009.114
56. Silke J. 2011. The regulation of TNF signalling: what a tangled web we weave. Current Opinion in Immunology 23:620-626. doi: 10.1016/j.coi.2011.08.002
57. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3:1-25. Article 3. doi: 10.2202/1544-6115.1027
58. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X. 2012. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213-227. doi: 10.1016/j.cell.2011.11.031
59. Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh W-C, Nakano H. 2001. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF- b activation and protection from cell death. Journal of Biological Chemistry 276:36530-36534. doi: 10.1074/jbc.M104837200
60. Takeuchi M, Rothe M, Goeddel DV. 1996. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. Journal of Biological Chemistry 271: 19935-19942. doi: 10.1074/jbc.271.33.19935
61. Tse MT. 2013. IL-17 antibodies gain momentum. Nature Reviews Drug Discovery 12:815-816. doi: 10.1038/nrd4152
62. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA-K, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist P-H, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Ponten F. 2015. Tissue-based map of the human proteome. Science 347:126-419. doi: 10.1126/science.1260419
63. Uren AG, Vaux DL. 1996. TRAF proteins and meprins share a conserved domain. Trends in Biochemical Sciences 21:244-245. doi: 10.1016/0968-0004(96)30022-4
64. Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng P-H, Keats JJ, Wang H, Vignali DAA, Bergsagel PL, Karin M. 2008. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nature Immunology 9:1364-1370. doi: 10.1038/ni.1678
65. van Nieuwenhuijze A, Koenders M, Roeleveld D, Sleeman MA, van den Berg W, Wicks IP. 2013. GM-CSF as a therapeutic target in inflammatory diseases. Molecular Immunology 56:675-682. doi: 10.1016/j.molimm.2013.05.002
66. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, Vucic D. 2008. C-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor (tNF)-induced NF- b activation. Journal of Biological Chemistry 283:24295-24299. doi: 10.1074/jbc.C800128200
67. Vince JE, Chau D, Callus B, Wong WW-L, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK, Yeoh G, Brink R, Vaux DL, Silke J. 2008. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNF. The Journal of Cell Biology 182:171-184. doi: 10.1083/jcb.200801010
68. Vince JE, Pantaki D, Feltham R, Mace PD, Cordier SM, Schmukle AC, Davidson AJ, Callus BA, Wong WW-L, Gentle IE, Carter H, Lee EF, Walczak H, Day CL, Vaux DL, Silke J. 2009. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tNF) to efficiently activate NF- b and to prevent TNF-induced apoptosis. Journal of Biological Chemistry 284:35906-35915. doi: 10.1074/jbc.M109.072256
69. Vince JE, Wong WW-L, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL, Silke J. 2007. IAP antagonists target cIAP1 to induce TNFa-dependent apoptosis. Cell 131:682-693. doi: 10.1016/j.cell.2007.10.037
70. Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, Lukens JR, Rodriguez DA, Gurung P, Savage C, Kanneganti TD, Green DR. 2013. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Reports 5:340-348. doi: 10.1016/j.celrep.2013.08.045
71. Wertz IE, O’Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430:694-699. doi: 10.1038/nature02794
72. Wong WW-L, Vince JE, Lalaoui N, Lawlor KE, Chau D, Bankovacki A, Anderton H, Metcalf D, O’Reilly L, Jost PJ, Murphy JM, Alexander WS, Strasser A, Vaux DL, Silke J. 2014. CIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood 123:2562-2572. doi: 10.1182/blood-2013-06-510743
73. Xiong Y, Lee HJ, Mariko B, Lu Y-C, Dannenberg AJ, Haka AS, Maxfield FR, Camerer E, Proia RL, Hla T. 2013. Sphingosine kinases are not required for inflammatory responses in macrophages. Journal of Biological Chemistry 288:32563-32573. doi: 10.1074/jbc.M113.483750
74. Yeh W-C, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715-725. doi: 10.1016/S1074-7613(00)80391-X
75. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD. 2001. Defective lymphotoxin-beta receptor-induced NF-kappa b transcriptional activity in NIK-deficient mice. Science 291:2162-2165. doi: 10.1126/science.1058453
76. Yin Q, Lamothe B, Darnay BG, Wu H. 2009. Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry 48:10558-10567. doi: 10.1021/bi901462e
77. Yoshiki R, Kabashima K, Honda T, Nakamizo S, Sawada Y, Sugita K, Yoshioka H, Ohmori S, Malissen B, Tokura Y, Nakamura M. 2014. IL-23 from langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing g t cellss. Journal of Investigative Dermatology 134: 1912-1921. doi: 10.1038/jid.2014.98
78. Zarnegar BJ, Wang Y, Mahoney DJ, Dempsey PW, Cheung HH, He J, Shiba T, Yang X, Yeh Wen-chen, Mak TW, Korneluk RG, Cheng G. 2008. Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nature Immunology 9:1371-1378. doi: 10.1038/ni.1676
79. Zhang L, Blackwell K, Shi Z, Habelhah H. 2010. The RING domain of TRAF2 plays an essential role in the inhibition of TNFa-induced cell death but not in the activation of NF-κB. Journal of Molecular Biology 396:528-539. doi: 10.1016/j.jmb.2010.01.008
80. Zhu S, Pan W, Shi P, Gao H, Zhao F, Song X, Liu Y, Zhao L, Li X, Shi Y, Qian Y. 2010. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. Journal of Experimental Medicine 207:2647-2662. doi: 10.1084/jem.20100703